GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Beneish M-Score

Biomaxima (WAR:BMX) Beneish M-Score : -1.72 (As of May. 25, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.72 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Biomaxima's Beneish M-Score or its related term are showing as below:

WAR:BMX' s Beneish M-Score Range Over the Past 10 Years
Min: -13.44   Med: -2.55   Max: -1.1
Current: -1.72

During the past 13 years, the highest Beneish M-Score of Biomaxima was -1.10. The lowest was -13.44. And the median was -2.55.


Biomaxima Beneish M-Score Historical Data

The historical data trend for Biomaxima's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomaxima Beneish M-Score Chart

Biomaxima Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.48 -1.93 -1.10 -13.44 -1.72

Biomaxima Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.44 1.05 0.18 -1.95 -1.72

Competitive Comparison of Biomaxima's Beneish M-Score

For the Diagnostics & Research subindustry, Biomaxima's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomaxima's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Biomaxima's Beneish M-Score falls into.



Biomaxima Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Biomaxima for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 2.6085+0.528 * 0.8522+0.404 * 0.858+0.892 * 0.3254+0.115 * 1.0835
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.013648-0.327 * 1.3039
=-1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was zł8.56 Mil.
Revenue was 13.347 + 11.666 + 10.727 + 11.076 = zł46.82 Mil.
Gross Profit was 5.279 + 4.75 + 5.589 + 5.409 = zł21.03 Mil.
Total Current Assets was zł22.83 Mil.
Total Assets was zł73.78 Mil.
Property, Plant and Equipment(Net PPE) was zł50.58 Mil.
Depreciation, Depletion and Amortization(DDA) was zł2.49 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.00 Mil.
Total Current Liabilities was zł10.44 Mil.
Long-Term Debt & Capital Lease Obligation was zł9.06 Mil.
Net Income was 0.093 + -0.366 + 0.384 + 0.475 = zł0.59 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = zł0.00 Mil.
Cash Flow from Operations was 0.913 + 3.529 + 0.233 + -3.082 = zł1.59 Mil.
Total Receivables was zł10.08 Mil.
Revenue was 13.35 + 13.045 + 23.876 + 93.596 = zł143.87 Mil.
Gross Profit was 3.277 + 5.446 + 9.324 + 37.021 = zł55.07 Mil.
Total Current Assets was zł36.23 Mil.
Total Assets was zł74.42 Mil.
Property, Plant and Equipment(Net PPE) was zł37.76 Mil.
Depreciation, Depletion and Amortization(DDA) was zł2.02 Mil.
Selling, General, & Admin. Expense(SGA) was zł2.66 Mil.
Total Current Liabilities was zł10.98 Mil.
Long-Term Debt & Capital Lease Obligation was zł4.11 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(8.559 / 46.816) / (10.083 / 143.867)
=0.182822 / 0.070086
=2.6085

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(55.068 / 143.867) / (21.027 / 46.816)
=0.38277 / 0.449141
=0.8522

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (22.833 + 50.58) / 73.783) / (1 - (36.225 + 37.761) / 74.421)
=0.005015 / 0.005845
=0.858

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=46.816 / 143.867
=0.3254

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.02 / (2.02 + 37.761)) / (2.487 / (2.487 + 50.58))
=0.050778 / 0.046865
=1.0835

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 46.816) / (2.655 / 143.867)
=0 / 0.018455
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((9.064 + 10.438) / 73.783) / ((4.11 + 10.976) / 74.421)
=0.264316 / 0.202712
=1.3039

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(0.586 - 0 - 1.593) / 73.783
=-0.013648

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Biomaxima has a M-score of -1.72 signals that the company is likely to be a manipulator.


Biomaxima Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Biomaxima's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomaxima (WAR:BMX) Business Description

Traded in Other Exchanges
Address
5 Vetterow Street, Lublin, POL, 20-277
Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Biomaxima (WAR:BMX) Headlines

No Headlines